Lipid diseases Flashcards
Autosomal Recessive.
Mutation in microsomal transfer protein (MTP)
Abetalipoproteinemia
Infants present with severe
fat malabsorption,
steatorrhea,
failure to thrive.
Abetalipoproteinemia
Lipoprotein lipase or apolipoprotein C-II deficiency
Hyper chylomicronemia
I
Defective/absent LDL receptors
or
Defective ApoB-100
Familial Hypercholesterolemia
II
Defective ApoE
Dysbeta-lipoproteinemia
III
Hepatic overproduction of VLDL
Hyper Triglyceridemia
IV
Blood levels:
↑ TG
↑ Cholesterol
↑ Chylomicrons
Hyper chylomicronemia
I
Blood levels:
↑ Cholesterol
↑ LDL
Familial Hypercholesterolemia
IIa
Blood levels:
↑ Chylomicrons
↑ VLDL
Dysbeta-lipoproteinemia
III
Blood levels:
↑TG
↑VLDL
Hyper Triglyceridemia
IV
Pancreatitis, hepatosplenomegaly, and eruptive/pruritic xanthomas (no risk for atherosclerosis).
Creamy layer in supernatant
Hyper chylomicronemia
I
Heterozygotes (1:500) have cholesterol ≈ 300 mg/dL
homozygotes (very rare) have cholesterol ≥ 700 mg/dL.
Familial Hypercholesterolemia
II
Premature atherosclerosis, tuberoeruptive and palmar xanthomas
Dysbeta-lipoproteinemia
III
TG (> 1000 mg/dL) can cause acute pancreatitis.
Related to insulin resistance.
Hyper Triglyceridemia
IV
Deficiency in ApoB-48, ApoB-100
Abetalipoproteinemia
Chylomicrons, VLDL, LDL absent
Abetalipoproteinemia
Later manifestations include: retinitis pigmentosa, spinocerebellar degeneration (vit E deficiency) Ataxia, acanthocytosis.
Abetalipoproteinemia
Treat with Long chain Fatty acid restriction
oral vitamin E
Abetalipoproteinemia
Intestinal biopsy shows lipid-laden enterocytes
Abetalipoproteinemia
Blood levels:
↑ Cholesterol
↑ LDL
↑ VLDL
Familial Hypercholesterolemia
IIb
Accelerated atherosclerosis
(may have MI before age 20),
Tendon (Achilles) xanthomas,
corneal arcus (cholesterol in iris)
Familial Hypercholesterolemia
II
no risk for atherosclerosis
Hyper chylomicronemia
I
May have MI before age 20
Familial Hypercholesterolemia
II
Chylomicron enters lympatics HDL transfers Apo C2 and Apo E Chylomicron Apo C2 activates LPL Liver Release VLDL VLDL Apo C2 activates LPL IDL delivers TGs & Cholesterol to Liver via Apo E Endocytosis of LDL
reveiw